Today's Date
Brentuximab vedotin in diffuse cutaneous systemic sclerosis
(
BRAVOS
)
ITN Protocol #:
ITN075AI
Branded Name:
BRAVOS
ClinicalTrials.Gov ID:
NCT03222492Treatment Protocol #:
Therapeutic Area:
Autoimmune Disease
Current Status:
Analysis
Summary:
Evaluation of Brentuximab Vedotin in Diffuse Cutaneous Systemic Sclerosis
Clinical Operations Associate Director
Clinical Operations Manager
ITN Biologist
ITN Clinical Trial Physician
NIAID Project Manager
Rho Data Manager
Study Personnel:
